Versant Venture Management as of June 30, 2017
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Audentes Therapeutics | 27.2 | $35M | 1.8M | 19.14 | |
| Achaogen | 21.9 | $28M | 1.3M | 21.74 | |
| Immune Design | 16.8 | $21M | 2.2M | 9.65 | |
| Ocular Therapeutix (OCUL) | 16.1 | $21M | 2.2M | 9.27 | |
| Clovis Oncology | 7.5 | $9.5M | 102k | 93.69 | |
| Cymabay Therapeutics | 4.8 | $6.0M | 1.0M | 5.76 | |
| Second Sight Med Prods | 4.4 | $5.6M | 4.5M | 1.25 | |
| Opgen | 1.3 | $1.6M | 2.6M | 0.65 |
